SME Times News Bureau | 19 Jun, 2018
government has released a study report on measures to increase
India's pharmaceutical exports to China.
India to make a strong pitch for pharma exports to China, the
Department of Commerce in coordination with Embassy of India at
Beijing commissioned a study on "Enhancing Indian Exports of
Pharmaceutical products to China" under the Market Access
Initiative Scheme (MAI), said an official release.
objective of the study is to have a proper understanding of Chinese
market and to help the Indian pharma industry to evolve appropriate
and focused strategy for entry of the Indian generic drugs.
study examines the health care market, pharmaceutical market the
distribution system, procurement and bidding process and the
regulatory landscape in China. The study also gives recommendations
on how to access the Chinese market.
China's health-care sector continues to grow rapidly with spending
projected to grow from $ 357 billion in 2011 to $ 1 trillion in 2020.
From pharmaceuticals to medical products to consumer health, China
remains among the world’s most attractive markets, and by far the
fastest-growing of all the large emerging ones.
study has been done by IMS Health team which worked with PHARMEXCIL
and Industry stakeholders.